S
RPRX icon

Sachetta’s Royalty Pharma RPRX Stock Holding History

Sachetta’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.11K Buy
109
+12
+12% +$625 ﹤0.01% 598
2026
Q1 		$4.65K Hold
97
– – ﹤0.01% 683
2025
Q4 		$3.75K Hold
97
– – ﹤0.01% 625
2025
Q3 		$3.42K Hold
97
– – ﹤0.01% 696
2025
Q2 		$3.5K Buy
97
+48
+98% +$1.59K ﹤0.01% 674
2025
Q1 		$1.53K Hold
49
– – ﹤0.01% 845
2024
Q4 		$1.25K Sell
49
-23
-32% -$610 ﹤0.01% 942
2024
Q3 		$2.04K Hold
72
– – ﹤0.01% 870
2024
Q2 		$2.06K Buy
72
+29
+67% +$804 ﹤0.01% 819
2024
Q1 		$1.21K Hold
43
– – ﹤0.01% 869
2023
Q4 		$1.21K Buy
+43
New +$1.18K ﹤0.01% 869

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sachetta's RPRX Position: Q2 2026 in Review

Sachetta increased its Royalty Pharma (RPRX) stake by 12% in Q2 2026, buying an estimated $625 and bringing the position to 109 shares worth $6.11K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

Sachetta first reported a position in RPRX in Q4 2023 and has held it in 11 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Sachetta held 109 shares of Royalty Pharma worth $6.11K as of Q2 2026.
  • Sachetta bought 12 Royalty Pharma shares in Q2 2026, an estimated $625.
  • Royalty Pharma made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #598 holding.
  • Sachetta first reported a position in Royalty Pharma in Q4 2023 and has held it in 11 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.